Research Article
Partial Block by Riluzole of Muscle Sodium Channels in Myotubes from Amyotrophic Lateral Sclerosis Patients
Table 1
Patients characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Demographic and clinical characteristics of the 11 patients with ALS evaluated during riluzole treatment (+Riluzole) and after 1-week withdrawal (−Riluzole). : average number (number in each insertion) of fibrillation potentials (Fibs); MRC lower limbs: Medical Research Council score for lower limbs; CMAP: amplitude of peroneal compound muscle action potential. Number of Fibs is not significantly affected by riluzole treatment ( by Wilcoxon test). |